SEC Form 4 · accession 0001708138-17-000011
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Aberman
Officer — SVP Strategy Investor Relation
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 21, 2017 | M | 4,500 | $30.63 | A | 9,193 | D | |
| Common Stock | Jun 21, 2017 | F | 270 | $510.02 | D | 8,923 | D | |
| Common Stock | Jun 21, 2017 | F | 1,961 | $510.02 | D | 6,962 | D | |
| Common StockF2 | Jun 22, 2017 | S | 395 | $525.21 | D | 6,567 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $526.02 | D | 6,467 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $529.61 | D | 6,367 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $530.66 | D | 6,267 | D | |
| Common StockF3 | Jun 22, 2017 | S | 274 | $531.51 | D | 5,993 | D | |
| Common StockF4 | Jun 22, 2017 | S | 200 | $532.27 | D | 5,793 | D | |
| Common StockF5 | Jun 22, 2017 | S | 200 | $533.48 | D | 5,593 | D | |
| Common StockF6 | Jun 22, 2017 | S | 200 | $534.51 | D | 5,393 | D | |
| Common StockF7 | Jun 22, 2017 | S | 400 | $536.52 | D | 4,993 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $537.50 | D | 4,893 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $538.30 | D | 4,793 | D | |
| Common Stock | Jun 22, 2017 | S | 100 | $541.00 | D | 4,693 | D | |
| Common Stock | holding | — | — | — | 11,805 | I | by GRAT | |
| Common Stock | holding | — | — | — | 448 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F8 | $30.63 | Jun 21, 2017 | M | 4,500 | D | — | Dec 14, 2020 | Common Stock | 4,500 | 3,000 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2Represents volume-weighted average price of sales of 395 shares of Company stock on June 22, 2017 at prices ranging from $525.00 to $525.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F3Represents volume-weighted average price of sales of 274 shares of Company stock on June 22, 2017 at prices ranging from $531.05 to $531.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F4Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $532.18 to $532.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F5Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $533.17 to $533.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F6Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $534.16 to $534.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F7Represents volume-weighted average price of sales of 400 shares of Company stock on June 22, 2017 at prices ranging from $536.15 to $536.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- F8The stock option award vests in four equal annual installments, commencing one year after the date of grant.